Company registration number SC458945 (Scotland)
EYEDENT MEDICS LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
PAGES FOR FILING WITH REGISTRAR
EYEDENT MEDICS LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
EYEDENT MEDICS LTD
BALANCE SHEET
AS AT
30 SEPTEMBER 2025
30 September 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
5
-
0
266
Investment property
6
345,000
345,000
345,000
345,266
Current assets
Cash at bank and in hand
398,954
338,615
Creditors: amounts falling due within one year
7
(16,780)
(11,027)
Net current assets
382,174
327,588
Total assets less current liabilities
727,174
672,854
Provisions for liabilities
(7,287)
(6,601)
Net assets
719,887
666,253
Capital and reserves
Called up share capital
100
100
Revaluation reserve
8
40,540
41,286
Profit and loss reserves
679,247
624,867
Total equity
719,887
666,253

For the financial year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 1 April 2026 and are signed on its behalf by:
Dr A Agrawal
Director
Company registration number SC458945 (Scotland)
EYEDENT MEDICS LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 2 -
1
Accounting policies
Company information

Eyedent Medics Ltd is a private company limited by shares incorporated in Scotland. The principal place of business is 62D St Albans Road, Edinburgh EH9 2LX and the registered office is 22 Stafford Street, Edinburgh, EH3 7BD.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied. There were no material departures from that standard.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of investment properties at fair value. The principal accounting policies adopted are set out below.

1.2
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 5 years.

1.4
Tangible fixed assets

Tangible fixed assets are stated at cost less accumulated depreciation and impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Equipment
33.33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Investment property

Investment property, which is property held to earn rentals is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value a t the reporting end date. The surplus or deficit on revaluation is recognised in the profit and loss account.

Where fair value cannot be achieved without undue cost or effort, investment property is accounted for as tangible fixed assets.

EYEDENT MEDICS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 3 -
1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are measured at transaction price. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are classified as debt and are recognised at transaction price. Financial liabilities classified as payable within one year are not amortised.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised at transaction price.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

EYEDENT MEDICS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 4 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

EYEDENT MEDICS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 5 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
1
1
4
Intangible fixed assets
Goodwill
£
Cost
At 1 October 2024 and 30 September 2025
20,000
Amortisation and impairment
At 1 October 2024 and 30 September 2025
20,000
Carrying amount
At 30 September 2025
-
0
At 30 September 2024
-
0
5
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 October 2024 and 30 September 2025
1,599
Depreciation and impairment
At 1 October 2024
1,333
Depreciation charged in the year
266
At 30 September 2025
1,599
Carrying amount
At 30 September 2025
-
0
At 30 September 2024
266
6
Investment property
2025
£
Fair value
At 1 October 2024 and 30 September 2025
345,000
EYEDENT MEDICS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
6
Investment property
(Continued)
- 6 -

Investment property comprises of two residential properties. The fair value of the investment property has been arrived at on the basis of a valuation carried out at 30 September 2025 by the director. The valuation was made on an open market value basis by reference to market evidence of transaction prices for similar properties.

7
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
14,836
8,606
Other creditors
312
312
Accruals and deferred income
1,632
2,109
16,780
11,027
8
Revaluation reserve
2025
2024
£
£
At the beginning of the year
41,286
41,286
Other movements
(746)
-
At the end of the year
40,540
41,286

Where assets are included at fair value, the unrealised uplift in their fair value is transferred from the profit and loss reserve to the non-distributable revaluation reserve. Deferred tax movements on these unrealised uplifts are also transferred from the profit and loss reserve to the revaluation reserve.

2025-09-30 2024-10-01 false false false 01 April 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Dr A Agrawal Mrs T Agrawal SC458945 2024-10-01 2025-09-30 SC458945 2025-09-30 SC458945 2024-09-30 SC458945 core:OtherPropertyPlantEquipment 2025-09-30 SC458945 core:OtherPropertyPlantEquipment 2024-09-30 SC458945 core:CurrentFinancialInstruments 2025-09-30 SC458945 core:CurrentFinancialInstruments 2024-09-30 SC458945 core:ShareCapital 2025-09-30 SC458945 core:ShareCapital 2024-09-30 SC458945 core:RevaluationReserve 2025-09-30 SC458945 core:RevaluationReserve 2024-09-30 SC458945 core:RetainedEarningsAccumulatedLosses 2025-09-30 SC458945 core:RetainedEarningsAccumulatedLosses 2024-09-30 SC458945 core:RevaluationReserve 2024-09-30 SC458945 core:RevaluationReserve 2023-09-30 SC458945 bus:Director1 2024-10-01 2025-09-30 SC458945 core:Goodwill 2024-10-01 2025-09-30 SC458945 core:ComputerEquipment 2024-10-01 2025-09-30 SC458945 2023-10-01 2024-09-30 SC458945 core:NetGoodwill 2024-09-30 SC458945 core:NetGoodwill 2025-09-30 SC458945 core:NetGoodwill 2024-09-30 SC458945 core:OtherPropertyPlantEquipment 2024-09-30 SC458945 core:OtherPropertyPlantEquipment 2024-10-01 2025-09-30 SC458945 2024-09-30 SC458945 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 SC458945 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 SC458945 bus:FRS102 2024-10-01 2025-09-30 SC458945 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 SC458945 bus:Director2 2024-10-01 2025-09-30 SC458945 bus:FullAccounts 2024-10-01 2025-09-30 xbrli:pure xbrli:shares iso4217:GBP